U.S. markets open in 9 hours 29 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
316.79+2.96 (+0.94%)
At close: 4:04PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/17/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
23.18B20.96B20.32B16.77B11.21B
Enterprise Value 3
22.89B20.77B20.20B16.76B11.10B
Trailing P/E
68.6768.6072.5365.4747.43
Forward P/E 1
53.4862.1162.8965.7943.48
PEG Ratio (5 yr expected) 1
4.544.755.036.83N/A
Price/Sales (ttm)
11.0810.5210.679.086.24
Price/Book (mrq)
12.5012.2012.6511.257.12
Enterprise Value/Revenue 3
10.6635.8036.8531.7922.58
Enterprise Value/EBITDA 7
44.13142.56157.54128.7096.91

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 389.97%
S&P500 52-Week Change 352.95%
52 Week High 3317.19
52 Week Low 3163.79
50-Day Moving Average 3281.60
200-Day Moving Average 3284.54

Share Statistics

Avg Vol (3 month) 3469.52k
Avg Vol (10 day) 3361.58k
Shares Outstanding 574.1M
Implied Shares Outstanding 6N/A
Float 73.59M
% Held by Insiders 10.64%
% Held by Institutions 195.06%
Shares Short (Mar 30, 2021) 4692.45k
Short Ratio (Mar 30, 2021) 41.63
Short % of Float (Mar 30, 2021) 41.06%
Short % of Shares Outstanding (Mar 30, 2021) 40.94%
Shares Short (prior month Feb 25, 2021) 4602k

Dividends & Splits

Forward Annual Dividend Rate 40.68
Forward Annual Dividend Yield 40.22%
Trailing Annual Dividend Rate 30.65
Trailing Annual Dividend Yield 30.21%
5 Year Average Dividend Yield 40.48
Payout Ratio 414.22%
Dividend Date 3May 04, 2021
Ex-Dividend Date 4Apr 19, 2021
Last Split Factor 22:1
Last Split Date 3Sep 26, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 16.12%
Operating Margin (ttm)19.57%

Management Effectiveness

Return on Assets (ttm)10.23%
Return on Equity (ttm)20.20%

Income Statement

Revenue (ttm)2.15B
Revenue Per Share (ttm)29.05
Quarterly Revenue Growth (yoy)23.30%
Gross Profit (ttm)767.8M
EBITDA 529.2M
Net Income Avi to Common (ttm)346.2M
Diluted EPS (ttm)4.57
Quarterly Earnings Growth (yoy)54.00%

Balance Sheet

Total Cash (mrq)615.5M
Total Cash Per Share (mrq)8.31
Total Debt (mrq)331.3M
Total Debt/Equity (mrq)17.86
Current Ratio (mrq)2.73
Book Value Per Share (mrq)25.05

Cash Flow Statement

Operating Cash Flow (ttm)472.5M
Levered Free Cash Flow (ttm)248.84M